Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct;92(10):1787-1788.
doi: 10.1002/jmv.25897. Epub 2020 Jun 29.

Off-label use of tocilizumab in patients with SARS-CoV-2 infection

Simona Di Giambenedetto  1   2 , Arturo Ciccullo  1 , Alberto Borghetti  1 , Giovanni Gambassi  3   4 , Francesco Landi  3   5 , Elena Visconti  1 , Lorenzo Zileri Dal Verme  6 , Roberto Bernabei  3   5 , Enrica Tamburrini  1   2 , Roberto Cauda  1   2 , Antonio Gasbarrini  6
Affiliations
Comment

Off-label use of tocilizumab in patients with SARS-CoV-2 infection

Simona Di Giambenedetto et al. J Med Virol. 2020 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Comment in

  • Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia.
    Mazzitelli M, Arrighi E, Serapide F, Pelle MC, Tassone B, Lionello R, Marrazzo G, Laganà D, Costanzo FS, Matera G, Trecarichi EM, Torti C. Mazzitelli M, et al. J Med Virol. 2021 Jan;93(1):32-34. doi: 10.1002/jmv.26016. Epub 2020 Sep 30. J Med Virol. 2021. PMID: 32410234 Free PMC article. No abstract available.

Comment on

References

    1. Pan L, Yi L, Lin Q, et al. Tocilizumab treatment in COVID‐19: a single center experience. J Med Virol. 2020;92(7):814‐818. - PMC - PubMed
    1. Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and corona virus disease‐2019 (COVID‐19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. - PMC - PubMed
    1. Sun P, Lu X, Xu C, Sun W, Pan B Understanding of COVID‐19 based on current evidence [published online ahead of print, 25 Feb 2020]. J Med Virol. 2020;92(6):548‐551. - PMC - PubMed
    1. Cao B, Wang Y, Wen D, et al. A trial of lopinavir‐ritonavir in adults hospitalized with severe Covid‐19 [published online ahead of print, 18 Mar 2020]. N Engl J Med. 2020;382:1787‐1799. - PMC - PubMed
    1. Gilead . Gilead Sciences Statement on the Company's Ongoing Response to the 2019 Novel Coronavirus (2019‐nCoV). https://www.gilead.com/news-and-press/company-statements/gilead-sciences...

Substances